DE CAROLIS, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 229
EU - Europa 196
AS - Asia 193
SA - Sud America 28
AF - Africa 4
Totale 650
Nazione #
US - Stati Uniti d'America 217
SG - Singapore 94
IT - Italia 80
CN - Cina 29
IE - Irlanda 29
HK - Hong Kong 28
BR - Brasile 25
RU - Federazione Russa 17
FI - Finlandia 16
DE - Germania 15
KR - Corea 15
VN - Vietnam 11
GB - Regno Unito 7
UA - Ucraina 7
MX - Messico 6
PL - Polonia 6
CA - Canada 5
JP - Giappone 5
CZ - Repubblica Ceca 4
ES - Italia 4
IN - India 4
SE - Svezia 4
BD - Bangladesh 3
FR - Francia 3
AT - Austria 2
ZA - Sudafrica 2
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
HN - Honduras 1
IL - Israele 1
LT - Lituania 1
MA - Marocco 1
ME - Montenegro 1
NE - Niger 1
PE - Perù 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 650
Città #
Singapore 62
Perugia 35
Dublin 29
Hong Kong 28
Ashburn 27
Chandler 25
Seoul 15
Boardman 12
Santa Clara 11
San Mateo 10
Altamura 8
Helsinki 8
Moscow 8
Munich 8
New York 8
The Dalles 7
Dallas 6
São Paulo 6
Beijing 5
Lawrence 5
Los Angeles 5
Medford 5
Princeton 5
Tokyo 5
Turku 5
Jacksonville 4
Piscataway 4
Rome 4
Verona 4
Hanoi 3
Houston 3
Olomouc 3
Querétaro 3
Boston 2
Brasília 2
Brooklyn 2
Ho Chi Minh City 2
Johannesburg 2
London 2
Manassas 2
Montreal 2
New Malden 2
Nuremberg 2
Orem 2
Warsaw 2
Wroclaw 2
Augusta 1
Baku 1
Barranquilla 1
Bebedouro 1
Bhopal 1
Biên Hòa 1
Boydton 1
Calgary 1
Cariacica 1
Casablanca 1
Chennai 1
Chicago 1
Chittagong 1
Chongqing 1
Denver 1
Des Moines 1
Falkenstein 1
Florence 1
Foligno 1
Frankfurt am Main 1
Guangzhou 1
Guariba 1
Hefei 1
Hưng Yên 1
Izmir 1
Jeddah 1
Juazeiro do Norte 1
Lappeenranta 1
Macaíba 1
Magé 1
Manchester 1
Maricá 1
Metter 1
Mexico City 1
Montignoso 1
Niamey 1
Nova Friburgo 1
Paramirim 1
Phủ Lý 1
Planalto 1
Podgorica 1
Poplar 1
Prague 1
Qingdao 1
Quận Chín 1
Recife 1
Ribeirão Preto 1
Saint Petersburg 1
Salt Lake City 1
San Francisco 1
San Rafael 1
Slidell 1
Stockholm 1
Sumaré 1
Totale 456
Nome #
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 112
Choroidal vasculature analysis in MEK inhibitor-associated retinopathy 96
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial 94
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia 81
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 78
How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors 71
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia 63
Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia 47
An unusual form of BRAF‐V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine 45
Real‐life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy‐cell leukemia: A multicenter Italian retrospective study (HCL‐PG03R) 11
Totale 698
Categoria #
all - tutte 3.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 1 3 8 0 2 0
2021/202281 0 5 0 0 1 0 0 6 16 12 28 13
2022/202397 5 18 2 4 9 7 1 4 38 5 4 0
2023/202465 6 3 2 0 0 4 11 0 6 3 19 11
2024/2025172 7 16 5 7 20 8 21 21 24 4 27 12
2025/2026240 33 17 23 56 79 32 0 0 0 0 0 0
Totale 698